Original Investigation
Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction

https://doi.org/10.1016/j.jacc.2018.04.039Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

Cardiac reserve is depressed in patients with heart failure and preserved ejection fraction (HFpEF). The mechanisms causing this are poorly understood.

Objectives

The authors hypothesized that myocardial injury might contribute to the hemodynamic derangements and cardiac reserve limitations that are present in HFpEF. Markers of cardiomyocyte injury, central hemodynamics, ventricular function, and determinants of cardiac oxygen supply–demand balance were measured.

Methods

Subjects with HFpEF (n = 38) and control subjects without heart failure (n = 20) underwent cardiac catheterization, echocardiography, and expired gas analysis at rest and during exercise. Central venous blood was sampled to measure plasma high-sensitivity troponin T levels as an index of cardiomyocyte injury.

Results

Compared with control subjects, troponins were more than 2-fold higher in subjects with HFpEF at rest and during exercise (p < 0.0001). Troponin levels were directly correlated with left ventricular (LV) filling pressures (r = 0.52; p < 0.0001) and diastolic dysfunction (r = −0.43; p = 0.002). Although myocardial oxygen demand was similar, myocardial oxygen supply was depressed in HFpEF, particularly during exercise (coronary perfusion pressure–time integral; 44 ± 9 mm Hg × s × min−1 × l × dl−1 vs. 30 ± 9 mm Hg × s × min−1 × l × dl−1; p < 0.0001), and reduced indices of supply were correlated with greater myocyte injury during exercise (r = −0.44; p = 0.0008). Elevation in troponin with exercise was directly correlated with an inability to augment LV diastolic (r = −0.40; p = 0.02) and systolic reserve (r = −0.57; p = 0.0003), greater increases in LV filling pressures (r = 0.55; p < 0.0001), blunted cardiac output response (r = −0.44; p = 0.002), and more severely depressed aerobic capacity in HFpEF.

Conclusions

Limitations in LV functional reserve and the hemodynamic derangements that develop secondary to these limitations during exercise in HFpEF are correlated with the severity of cardiac injury, assessed by plasma levels of troponin T. Further study is warranted to determine the mechanisms causing myocyte injury in HFpEF and the potential role of ischemia, and to identify and test novel interventions targeted to these mechanisms. (EXEC [Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease]; NCT01418248)

Key Words

biomarkers
exercise
heart failure
hemodynamics
HFpEF
troponin T

Abbreviations and Acronyms

BMI
body mass index
CV
coefficient of variation
GDF
growth differentiation factor
HF
heart failure
HFpEF
heart failure and preserved ejection fraction
LV
left ventricular
NT-proBNP
N-terminal pro–B-type natriuretic peptide
PA
pulmonary artery
PCWP
pulmonary capillary wedge pressure
PTI
pressure–time integral
PTIC
corrected pressure–time integral
QC
cardiac output
RAP
right atrial pressure
RPP
rate–pressure product
Vo2
oxygen consumption

Cited by (0)

This research was supported by a competitive prospective grants award from the Mayo Clinic and Foundation. Dr. Obokata is supported by a research fellowship from the Uehara Memorial Foundation, Japan. Dr. Reddy is supported by T32 HL007111 from the National Institutes of Health. Dr. Melenovsky is supported by the Czech Healthcare Research Grant agency (AZV): 17-28784A. Dr. Olson is supported by RO1 HL126638 from the National Institutes of Health. Dr. Borlaug is supported by RO1 HL128526, RO1 HL126638, UO1 HL125205, and U10 HL110262 all from the National Institutes of Health. Dr. Jarolim has received research grants from Abbott Laboratories, Amgen, AstraZeneca, Daiichi-Sankyo, GlaxoSmithKline, Merck & Co., Roche Diagnostics Corporation, Takeda Global Research and Development Center, and Waters Technologies Corporation. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Listen to this manuscript's audio summary by JACC Editor-in-Chief Dr. Valentin Fuster.